OBALON THERAPEUTICS INC 4
4 · OBALON THERAPEUTICS INC · Filed Oct 14, 2016
Insider Transaction Report
Form 4
DP VII ASSOCIATES LP
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2016-10-12−11,083→ 0 total→ Common Stock (14,716 underlying) - Conversion
Common Stock
2016-10-12+49,570→ 49,570 total - Conversion
Series B Preferred Stock
2016-10-12−20,583→ 0 total→ Common Stock (20,583 underlying) - Conversion
Series C Preferred Stock
2016-10-12−14,271→ 0 total→ Common Stock (14,271 underlying)
Footnotes (3)
- [F1]The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- [F2]As managing members of the sole general partner of Domain Partners VII, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by Domain Partners VII, L.P., as reported on a Form 4 for Domain Partners VII, L.P. filed on the same date as this Form 4.
- [F3]All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date.